Spero Therapeutics, Inc. (SPRO)
2.55
-0.02
(-0.78%)
USD |
NASDAQ |
Jan 09, 16:00
2.555
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Accounts Payable (Quarterly): 1.395M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 389.67M |
| Amicus Therapeutics, Inc. | 19.10M |
| Cassava Sciences, Inc. | 46.09M |
| Omeros Corp. | 12.50M |
| GeoVax Labs, Inc. | 0.9764M |